OLV Hospital, Aalst, Belgium Report issue

Academic/Hospital Phase 4
Founded: Aalst Belgium (1904)

Organization Overview

First Clinical Trial
2011
NCT01675206
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

OLV Hospital Aalst Belgium | OLV Hospital, Anesthesiology and CCM, Aalst, Belgium

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Calcinosis (Phase 4)

Heart Failure (Phase 3)

Vascular Calcification (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5